• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Synthetic Platelets Offer Potential Benefits for Platelet-Associated Disorders

July 20, 2012

Professor Nishit Doshi and colleagues from the University of California, Santa  Barbara, the Scripps Research Institute, and Sanford-Burnham Medical Research Institute have reported progress in developing synthetic platelets.  They synthesized platelets, imitating the size, shape, and adhesive properties, among other attributes, of mammalian platelets, and concluded that the synthetic particles were highly successful and could have major therapeutic applications.


Reference:

Doshi N, Orje JN, Molins B, Smith JW, Mitragorti S, Ruggeri ZM. Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood. Adv Mater 2012.

Image Source:  Doshi N, Orje JN, Molins B, Smith JW, Mitragorti S, Ruggeri ZM. Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood. Adv Mater 2012.

Filed Under

  • News
  • Platelet Transfusion

Recommended

  • Increased Risk of Myocardial Ischemia and Death in Severely Anemic Patients who Decline Transfusions

  • Urgent Global Need of Blood Products

  • Restrictive Transfusion Strategy for Cardiac Surgery Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley